कृपया अन्य खोज का प्रयास करें
Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
James Wakefield | - | 2014 | Independent Non-Executive Chairman of the Board |
Steve Gibson | - | 2017 | CFO & Director |
Jean-Pierre Crinelli | - | - | Independent Non-Executive Director |
Isabelle Cartier | - | - | Member of Scientific Committee |
Geneviève Bourg-Heckly | - | - | Member of Scientific Committee |
Marco Zonta | - | - | Member of Scientific Committee |
David Gardner | - | - | Member of Scientific Committee |
Andrew John William Heath | 76 | 2015 | Independent Senior Non-Executive Director |
John Robert Brown | 69 | 2023 | Non-Executive Director |
Lyn Dafydd Rees | 51 | 2023 | CEO & Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है